Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.gujaratinject.in | |
Market Cap | 4.46 Cr. | |
Enterprise Value(EV) | 5.30 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.09 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 96.92 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 37.97 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | -1.60 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | -5.68 | Calculated using Price: 9.10 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.49 Cr. | 4,899,000 Shares |
FaceValue | 10 | |
About Gujarat Inject (Kerala) Ltd. | ||
Gujarat Inject (Kerala) (GKIL) was incorporated on January 7, 1991 and obtained certificate for commencement of business on February 14, 1991. The company has been jointly promoted by the Kerala State Industrial Development Corporation (KSIDC), a wholly owned subsidiary of Government of Kerala undertaking and Gujarat Inject (GIL) and its associates. The company has received SIA registration to manufacture intravenous solutions at puddussey east, kanjikode, in palghat district in Kerala. |
1 Day |
|
-4.91% |
1 Week |
|
|
1 Month |
|
+2.48% |
3 Month |
|
+8.59% |
6 Month |
|
-1.09% |
1 Year |
|
+33.82% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | ||||||||||
Return on Capital Employed (%) | ||||||||||
Return on Assets (%) | -1.84 | 1,373.74 | 6.93 | -102.49 | -30.20 | 1.57 | -664.44 | 5.37 | 22.31 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | -3 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
Minority Int. | |||||||||||
Equity & Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Non Curr. Assets | 0 | 0 | 0 | ||||||||
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 0 | 2 | 0 | 0 | 0 | 0 | |||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Total Income | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||
Total Expenditure | 0 | -2 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | ||
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Interest | |||||||||||
Depreciation | |||||||||||
Taxation | 0 | 0 | |||||||||
Exceptional Items | 2 | ||||||||||
PAT | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Adjusted EPS | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | ||||||||
Cash Fr. Inv. | |||||||||||
Cash Fr. Finan. | 0 | ||||||||||
Net Change | 0 | 0 | |||||||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Wed, 22 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. Wednesday November 22 2023 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 In reference to captioned subject we hereby inform you that the Board of Directors of the Company in their Board Meeting held on today i.e. on Wednesday November 22 2023 at the Administrative Office of the Company which was commenced at 03:30 P.M. and concluded at 04:15 P.M. have inter alia:1) To took note of the withdrawal of proposal for raising funds by way of acceptance of unsecured Loans with an option of conversion into equity shares of Gujarat Inject Kerala Limited subject to obtaining requisite approval of the shareholders of the Company.There is no other business to be transacted apart from this. |
Sat, 18 Nov 2023
Closure of Trading Window The trading window for dealing in Equity shares of the Company by the Insiders covered under Companys code of Internal procedures and conduct for prevention of Insider trading in securities has already been closed 17/11/2023 and shall remain closed till 48 hours after declaration and publication of outcome of Board meeting to be held on 22/11/2023 |
Fri, 17 Nov 2023
Board Meeting Intimation for Board Meeting Scheduled To Be Held On 22/11/2023 GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/11/2023 inter alia to consider and approve 1) acceptance of unsecured Loans with an option of conversion into equity shares of Gujarat Inject Kerala Limited subject to obtaining requisite approval of the shareholders of the Company; 2) an increasing borrowing limits in excess of the limit specified under section 180(1)(c) of Companies Act 2013 subject to obtaining requisite approval of the shareholders of the Company and 3) Any other items of business |
Tue, 28 Nov 2023 |
|
|
|
|
|